NEW COMBINATIONS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA OR CHRONIC MYELOID LEUKEMIA

摘要

The invention relates to combinations of N- [2- (2,1,3-benzothiadiazol-5-ylamino) -6- (2,6-dichlorophenyl) pyrido [2,3-d] pyrimidin-7-yl] -N'- (1,1-dimethylethyl) urea and cytarabine and their use for the treatment of AML or CML.